FDA Approved: GRANIX — Supplemental Application (Cephalon, LLC)

View source ↗

Summary

FDA approved a supplemental application for GRANIX (tbo-filgrastim) submitted by Cephalon, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Neutropenia

Drugs mentioned

• GRANIX (tbo-filgrastim)

Snippet

SUPPL AP for GRANIX (TBO-FILGRASTIM)